All data are based on the daily closing price as of November 18, 2026
e
Euglena
2931.TSE
1.93 USD
-0.04
-2.03%
Overview
Last close
1.93 usd
Market cap
268.88M usd
52 week high
3.46 usd
52 week low
1.92 usd
Target price
2.51 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
0.82
Price/Book Value
1.3601
Enterprise Value
318.83M usd
EV/Revenue
0.9537
EV/EBITDA
15.7466
Key financials
Revenue TTM
334.31M usd
Gross Profit TTM
231.02M usd
EBITDA TTM
41.20M usd
Earnings per Share
-0.01 usd
Dividend
0.01 usd
Total assets
432.75M usd
Net debt
36.45M usd
About
Euglena Co., Ltd. engages in the research, development, production, and sale of microalgae in Japan. It operates through there segments: Healthcare Business; Biofuel Business; and Other businesses. The company manufactures and sells health foods and cosmetics utilizing microalgae, such as euglena and chlorella. In addition, the company develops biofuel technology and environmental related technology for microalgae and industrial waste oil; development and research in agriculture business comprising feed and fertilizer, bioinformatics, and social businesses; and invests in biotechnology related businesses. Further, the company provides genome analysis services. Euglena Co., Ltd. was incorporated in 2005 and is headquartered in Tokyo, Japan.